Alpha/beta blockers are a category of sympatholytic medications.
Used for treating:
Hypertension
Heart failure (commonly alongside digoxin, ACE inhibitors, and diuretics)
Prolong survival chance post-myocardial infarction (MI)
Prototype Medication: Carvedilol
Expected Pharmacologic Action:
Block both alpha and beta receptors in the heart, arterioles, and kidney.
Alpha Receptor Blockade:
Causes dilation of arterioles by blocking peripheral alpha1 receptors.
Beta1 Receptor Blockade:
Reduces heart rate and contractility by blocking cardiac beta1 receptors.
Decreases renin release by blocking kidney beta1 receptors.
Overall effects:
Decreased resistance in blood vessels
Decreased cardiac output
Increased excretion of water and sodium
Common side effects include:
Dizziness
Hypotension
Bradycardia (especially from beta1 receptor blockade)
Other potential reactions:
Postural hypotension
Exacerbation of asthma
Blood Pressure Monitoring:
Regularly monitor blood pressure; report hypotension.
Heart Rate Monitoring:
Monitor heart rate; report rates below 60 beats per minute.
Safety Alert:
Concurrent use with other antihypertensives can lead to bradycardia.
Ensure heart rate is above 60 before administration; hold if below and notify provider.
Prepare to administer atropine and isoproterenol for symptomatic clients.
Carvedilol is indicated for:
Oral use only
Administer with food to minimize orthostatic hypotension.
Advise clients to:
Report dizziness or syncope to the provider.
Move slowly from lying to standing to prevent falls.
Avoid hazardous activities (e.g., driving) until aware of medication effects.
Check pulse daily; report rates less than 60 beats per minute.
Do not administer to clients with:
Severe, unstable heart failure
Asthma/bronchospastic disorders
Heart block or severe bradycardia
Cardiogenic shock
Pregnancy/lactation
Caution with:
Children under 18
Clients with diabetes, renal/hepatic disorders, peripheral vascular disease
Carvedilol interactions:
Concurrent use with insulin/oral hypoglycemics may alter hypoglycemic effects.
Higher risk of bradycardia when taken with digoxin.
Co-administration with MAO inhibitors may lead to bradycardia or hypotension.
Cimetidine can increase blood levels of alpha/beta blockers.
Increased risk for hypotension when combined with other antihypertensives.